Remarkable response to Osimertinib plus Gumarontinib for EGFR mutation and concomitant MET exon 14 skipping in a patient with lung adenocarcinoma: A case report.
Saved in:
| Title: | Remarkable response to Osimertinib plus Gumarontinib for EGFR mutation and concomitant MET exon 14 skipping in a patient with lung adenocarcinoma: A case report. |
|---|---|
| Authors: | Jing, Xuquan1 (AUTHOR), Li, Li1,2 (AUTHOR), Lu, Shuangqing1 (AUTHOR), Zhai, Xiaoyang1 (AUTHOR), Zhu, Hui1 (AUTHOR) drzhuh@126.com |
| Source: | Oncology Letters. Jan2026, Vol. 31 Issue 1, pN.PAG-N.PAG. 1p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
